The content of this website is intended for United States audiences only.
AFFIRM: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis (AFFIRM)
To Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis.
View MoreAge
18 Years +
Sex
ALL
Healthy Volunteers
No
Medical Condition
Primary Biliary Cholangitis
Gender
N/A
Date
September 2023 - August 2030
Study Type
INTERVENTIONAL
Study Phase
PHASE3
Product
Seladelpar, Placebo
Lancaster, California, United States, 93534
Los Angeles, California, United States, 90027
Los Angeles, California, United States, 90048
Pasadena, California, United States, 91105
Sacramento, California, United States, 95817
San Francisco, California, United States, 94109
San Francisco, California, United States, 94143
Fort Myers, Florida, United States, 33912
Miami, Florida, United States, 33136
Sarasota, Florida, United States, 33912
Tampa, Florida, United States, 34211
Atlanta, Georgia, United States, 30309
Chicago, Illinois, United States, 60637
Iowa City, Iowa, United States, 52242
Louisville, Kentucky, United States, 40202
Jefferson, Louisiana, United States, 70121
New Orleans, Louisiana, United States, 70112
Baltimore, Maryland, United States, 21202
Boston, Massachusetts, United States, 02114
Boston, Massachusetts, United States, 02215
Detroit, Michigan, United States, 48202
Manhasset, New York, United States, 11030
New York, New York, United States, 10016
New York, New York, United States, 10029
Winston-Salem, North Carolina, United States, 27157
Cleveland, Ohio, United States, 44106
Hershey, Pennsylvania, United States, 17033
Philadelphia, Pennsylvania, United States, 19107
Pittsburgh, Pennsylvania, United States, 15213
Cordova, Tennessee, United States, 38018
Dallas, Texas, United States, 75203
Dallas, Texas, United States, 75390
San Antonio, Texas, United States, 78229
Fairfax, Virginia, United States, 22031
Newport News, Virginia, United States, 23602
Richmond, Virginia, United States, 23298
Seattle, Washington, United States, 98105
Buenos Aires, Argentina, 1181
Buenos Aires, Argentina, 1426
Buenos Aires, Argentina, C1061
Buenos Aires, Argentina, C1061
Buenos Aires, Argentina, C1430
Recoleta, Argentina, C1118AAT
Adelaide, South Australia, Australia, 5042
Clayton, Victoria, Australia, 3168
Melbourne, Victoria, Australia, 3004
Vienna, Austria, 1020
Wels, Austria, 4600
Vancouver, Canada, V6G 2Z6
La Serena, Chile, 1720506
Santiago, Chile, 8320000
Santiago, Chile, 8330336
Valdivia, Chile, 5110683
Pilsen, Czechia, 301 00
Lyon, France, 69317
Montipellier, France, 34295
Kaposvár, Hungary, 7400
Cuernavaca, Mexico, 62170
Mexico City, Mexico, 6700
México, Mexico, 76806
Mysłowice, Poland, 41-400
Wroclaw, Poland, 52-210
Bucharest, Romania, 022328
Singapore, Singapore, 119228
Busan, South Korea, 49241
Daegu, South Korea, 41944
Gwangju, South Korea, 61455
Seongnam, South Korea, 13620
Seoul, South Korea, 05505
Seoul, South Korea, 3080
Seoul, South Korea, 3722
Seoul, South Korea, 6351
Barcelona, Spain, 08003
Barcelona, Spain, 08035
Barcelona, Spain, 08036
Córdoba, Spain, 14004
Málaga, Spain, 29010
Bern, Switzerland, 3010
Zurich, Switzerland, 8091
Adana, Turkey (Türkiye), 1370
Ankara, Turkey (Türkiye), 06800
Gaziantep, Turkey (Türkiye), 27630
Görükle, Turkey (Türkiye), 16059
Izmir, Turkey (Türkiye), 35040
Karabağlar, Turkey (Türkiye), 35150
Kocaeli, Turkey (Türkiye), 41380
Mersin, Turkey (Türkiye), 33110
Pendik, Turkey (Türkiye), 34899
Rize Merkez, Turkey (Türkiye), 53020
Share Trial